Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors — Stella

Home/Solid Tumor/A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Solid Tumor trials

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality

Key details

Phase

Early testing

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Enrollment target

~22 participants

Started

February 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.